Modafinil
In the US, Modafinil (modafinil systemic) is a member of the drug class CNS stimulants and is used to treat ADHD, Chronic Fatigue Syndrome, Depression, Fatigue, Hypersomnia, Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome and Shift Work Sleep Disorder.
US matches:
UK matches:
- MODAFINIL 100 MG TABLETS (Leaflet)
- MODAFINIL 100MG TABLETS (Leaflet)
- MODAFINIL 200 MG TABLETS (Leaflet)
- MODAFINIL 200MG TABLETS (Leaflet)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N06BA07
CAS registry number (Chemical Abstracts Service)
0068693-11-8
Chemical Formula
C15-H15-N-O2-S
Molecular Weight
273
Therapeutic Categories
Central stimulant
Sympathomimetic agent
Chemical Names
(RS)-2-[(Diephenylmetyl)sulfinyl]acetamid (IUPAC)
2-[(Diphenylmetyl)sulfinyl]acetamide (WHO)
Foreign Names
- Modafinilum (Latin)
- Modafinil (German)
- Modafinil (French)
- Modafinilo (Spanish)
Generic Names
- Modafinil (OS: BAN, DCF, USAN, JAN)
- CEP 1538 (IS)
- CRL 40476 (IS)
- Modafinil (PH: BP 2016, Ph. Eur. 8, USP 38)
- Modafinilum (PH: Ph. Eur. 8)
Brand Names
- Alertec
Shire, Canada - Alertex
Eurolab, Chile; Saval, Ecuador - Altasomil
Altamedics, Slovenia - Aspendos
Medochemie, Bulgaria; Medochemie, Cyprus; Medochemie, Netherlands; Medochemie, Romania; Medochemie, Slovakia - Forcilin
LKM, Argentina - Intensit
AstraZeneca, Argentina - Mentix
Royal Pharma, Chile - Modafinil Aurobindo
Aurobindo, Malta; Aurobindo, Netherlands; Aurobindo Pharma - Milpharm, United Kingdom - Modafinil Biogaran
Biogaran, France - Modafinil Bluefish
Bluefish Pharma, Sweden; Bluefish Pharmaceuticals, Iceland - Modafinil Chanelle
Chanelle, Netherlands - Modafinil EG
EG Labo, France - Modafinil Generis
Generis, Portugal - Modafinil Genus
Genus Pharmaceuticals, United Kingdom - Modafinil Medochemie
Medochemie, Netherlands - Modafinil Mylan
Mylan, Denmark; Mylan, France; Mylan, Netherlands; Mylan, Sweden - Modafinil Orchid
Orchid, Netherlands - Modafinil Teva
Teva Pharmaceuticals, United Kingdom - Modafinil Wynn
Wynn, Portugal - Modafinil-Acino
Acino Pharma, Switzerland - Modafinil-neuraxpharm
neuraxpharm, Germany - Modanil
Hanmi, South Korea - Modasomil
Teva Pharma, Austria; Teva Pharma, Switzerland - Modavigil
bioCSL, New Zealand; CSL, Australia - Modiodal
2care4, Norway; Alfresa Pharma, Japan; Cephalon, Netherlands; Cephalon, Tunisia; Euro Registratie, Netherlands; Gen, Turkey; Genesis, Greece; Lundbeck, Mexico; Medcor, Netherlands; MSD, Sweden; Noventure, Spain; Orifarm, Norway; Teva, Denmark; Teva, Iceland; Teva, Netherlands; Teva, Norway; Teva Pharma, Portugal; Teva Santé, France - Modiwake
Generica, Turkey - Movigil
Laboratorio Bago, Chile - Provigil
Cephalon, United States; MSD Belgium, Belgium; P & D, Malta; Taiwan Biotech, Taiwan; Teva Italia, Italy; Teva Pharma, Israel; Teva Pharmaceuticals, United Kingdom - Resotyl
Drugtech, Chile; Farmindustria, Peru - Stavigile
Libbs, Brazil - Vigia
Procaps, Colombia - Vigicer
Beta, Argentina - Vigil
Teva, Germany; Torrex, Czech Republic - Vigimax
Laboratorios Pharmavita, Chile - Zalux
Laboratorio Chile, Chile
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
DCF | Dénomination Commune Française |
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.